Pharmacological Profile And Clinical Outcomes Of Kte-X19 By Prior Bruton Tyrosine Kinase Inhibitor Exposure Or Mantle Cell Lymphoma Morphology In Patients With Relapsed/Refractory Mantle Cell Lymphoma In The Zuma-2 Trial

BRITISH JOURNAL OF HAEMATOLOGY(2021)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要